Brown & Brown (BRO) has experienced notable share price volatility, with Barclays maintaining an Equal-Weight recommendation and a reduction of the price target by Morgan Stanley. There has been a significant pullback in share price, and the price target has been decreased by 10.76%. The company's net profit margin has seen a decline, challenging the growth narrative despite beating earnings forecasts. Barclays issued a pessimistic forecast for BRO's stock, and Goldman Sachs cut their price target while maintaining a neutral rating. Despite a share slump, investments remain strong with notable players like Rep. Byron Donalds and the Vanguard Group buying shares. The Q3 earnings beat estimates, but the valuation is under examination after the share price decline. The company's revenue surge and a 10% dividend hike have potentially impacted the investment narrative. Despite a 10% slump on disappointing Q2 earnings, the company sees potential for recovery after key acquisitions. After a consolidation of business segments following the RSC Topco Acquisition, the stock price target was revised to $114. The company has authorized a $1.5B buyback with a 10% increase in quarterly dividends. A majority of BRO's activities have been focused on acquisitions and leadership overhauls to better streamline their operations.
Brown Brown BRO News Analytics from Tue, 25 Feb 2025 08:00:00 GMT to Sat, 22 Nov 2025 11:37:15 GMT -
Rating -5
- Innovation 3
- Information 8
- Rumor 1
